Parkside Financial Bank & Trust’s Fractyl Health GUTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.16K Sell
1,463
-14,201
-91% -$10.1K ﹤0.01% 2357
2026
Q1
$7.17K Sell
15,664
-640
-4% -$590 ﹤0.01% 1694
2025
Q4
$35.9K Hold
16,304
﹤0.01% 1087
2025
Q3
$25.9K Hold
16,304
﹤0.01% 1155
2025
Q2
$26.4K Buy
16,304
+2,971
+22% +$4.8K ﹤0.01% 1130
2025
Q1
$15.9K Hold
13,333
﹤0.01% 1233
2024
Q4
$27.5K Buy
+13,333
New +$31K ﹤0.01% 993

Other funds holding GUTS

Parkside Financial Bank & Trust's GUTS Position: Q2 2026 in Review

Parkside Financial Bank & Trust reduced its Fractyl Health (GUTS) stake by 91% in Q2 2026, selling an estimated $10.1K and leaving 1,463 shares worth $1.16K. The position accounts for ﹤0.01% of the portfolio, ranked #2357.

Parkside Financial Bank & Trust first reported a position in GUTS in Q4 2024 and has held it in 7 quarters since. The position peaked at $35.9K in Q4 2025. 77 funds tracked by Wall St. Rank hold GUTS as of Q2 2026.

  • Parkside Financial Bank & Trust held 1,463 shares of Fractyl Health worth $1.16K as of Q2 2026.
  • Parkside Financial Bank & Trust sold 14,201 Fractyl Health shares in Q2 2026, an estimated $10.1K.
  • Fractyl Health made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #2357 holding.
  • Parkside Financial Bank & Trust first reported a position in Fractyl Health in Q4 2024 and has held it in 7 quarters since.
  • Parkside Financial Bank & Trust's Fractyl Health position peaked at $35.9K in Q4 2025.
  • 77 funds tracked by Wall St. Rank held Fractyl Health as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.